Alpha 2.0
Login Register
» Authors » Manuel F Jimenez Navarro

Manuel F Jimenez Navarro

Explore the profile of Manuel F Jimenez Navarro including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 69
Followers 0
Related Specialties
Cardiology & Vascular Diseases
General Medicine
Top 10 Co-Authors
Armando Perez de Prado
Tamara Garcia Camarero
Jose M de la Torre Hernandez
Eduardo de Teresa Galvan
Angel Sanchez Recalde
Jaime Elizaga
Fernando Alfonso
Gerard Roura
Francisco Bosa
Ramon Calvino
Published In
Rev Esp Cardiol
Am J Cardiol
Med Clin (Barc)
JACC Cardiovasc Interv
Clin Cardiol
Affiliations
Soon will be listed here.
Recent Articles
1.
Comparison of paclitaxel and everolimus-eluting stents in ST-segment elevation myocardial infarction and influence of thrombectomy on outcomes. ESTROFA-IM study
de la Torre Hernandez J, Alfonso F, Martin Yuste V, Sanchez Recalde A, Jimenez Navarro M, de Prado A, et al.
Rev Esp Cardiol (Engl Ed) . 2014 Nov; 67(12):999-1006. PMID: 25432710
Introduction And Objectives: We sought to compare the long-term clinical outcome of with ST-segment elevation myocardial infarction treated with paclitaxel-eluting stents or everolimus-eluting stents and the influence of thrombectomy on...
2.
Clinical impact of intravascular ultrasound guidance in drug-eluting stent implantation for unprotected left main coronary disease: pooled analysis at the patient-level of 4 registries
de la Torre Hernandez J, Baz Alonso J, Gomez Hospital J, Alfonso Manterola F, Garcia Camarero T, Gimeno de Carlos F, et al.
JACC Cardiovasc Interv . 2014 Mar; 7(3):244-54. PMID: 24650399
Objectives: This study sought to investigate the clinical impact of the use of intravascular ultrasound (IVUS) during revascularization of patients with left main coronary artery (LM) disease with drug-eluting stents...
3.
Comparison of paclitaxel-eluting stents (Taxus) and everolimus-eluting stents (Xience) in left main coronary artery disease with 3 years follow-up (from the ESTROFA-LM registry)
de la Torre Hernandez J, Alfonso F, Sanchez Recalde A, Jimenez Navarro M, de Prado A, Hernandez F, et al.
Am J Cardiol . 2013 Jan; 111(5):676-83. PMID: 23273715
Evidence regarding therapy with drug-eluting stents in the left main coronary artery (LM) is based mostly on trials performed with first-generation drug-eluting stents. The aim of this study was to...
4.
Clinical impact of drug-eluting stents in an unselected population of diabetic patients
Dominguez Franco A, Briales J, Jimenez Navarro M, Hernandez Garcia J, Garcia Pinilla J, Perez Caravante M, et al.
Clin Cardiol . 2008 Apr; 31(4):165-71. PMID: 18404726
Background: Drug-eluting stents (DES) have been shown in randomized trials to reduce clinical events in diabetic patients. Our aim was to determine whether these clinical results are applicable in an...
5.
[Heart failure in 2005]
Jimenez Navarro M, Diez Martinez J, Delgado Jimenez J, Crespo Leiro M
Rev Esp Cardiol . 2006 Mar; 59 Suppl 1:55-65. PMID: 16540021
This article is a review of developments reported in the field of heart failure in the last year. It covers advances in epidemiology, pathophysiology and therapy, including cardiac resynchronization therapy...
6.
[Applicability of the clinical trials outcomes in heart failure to older people]
Munoz Garcia A, Sanchez Gonzalez C, Jimenez Navarro M, de Teresa Galvan E
Med Clin (Barc) . 2005 Apr; 124(14):558. PMID: 15847761
No abstract available.
7.
[Systolic ventricular dysfunction, a new marker of coronary artery disease in patients with aortic stenosis without previous myocardial infarction]
Perez Cabeza A, Gomez Doblas J, Morcillo Hidalgo L, Cabrera Bueno F, Jimenez Navarro M, Lopez Salguero R, et al.
Rev Esp Cardiol . 2005 Mar; 58(2):218-21. PMID: 15743568
Identification of clinical factors associated with coronary artery disease could obviate the need for coronary angiography in selected patients with severe aortic stenosis. We studied 315 patients (68 [8] years)...